Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652197 · ClinicalTrials.gov registry record
Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 16
- Enrollment target
NCT00652197: Completed study, sponsored by Transonic Systems.
NCT00652197 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00652197 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The study hypothesis is that an ultrasonic flow sensor can accurately measure flow in hydrocephalic shunts. The ultrasonic sensor will measure cerebro-spinal fluid drainage in hydrocephalus patients with external ventriculostomies and extra-ventricular drainage systems. The sensor measurements will be compared with the volume of fluid collected by the drainage bag. After a 24-hour measurement period, the doctor will change the drainage bag position to simulate the patient sitting up and leaning back, to see if this temporarily stops flow through the drainage line. This data will show whether the sensor accurately measures typical drainage flows seen in hydrocephalus patients. This research will help develop an implantable flow monitor for pediatric hydrocephalus patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-05 |
What the finished NCT00652197 record still lists
NCT00652197 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00652197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00652197 about?
NCT00652197 is a clinical study titled "Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor". The study hypothesis is that an ultrasonic flow sensor can accurately measure flow in hydrocephalic shunts. The ultrasonic sensor will measure cerebro-spinal fluid drainage in hydrocephalus patients with external ventriculostomies and extra-ventricular drainage systems. The sensor measurements will...
What is the current status of trial NCT00652197?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2009-03. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT00652197?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia